Kynam Capital holds 2.23% of enGene shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kynam Capital Management and related reporting persons disclose a 2.23% beneficial stake in enGene Holdings Inc. common shares on an amended Schedule 13G. They report beneficial ownership of 1,492,898 common shares, with shared voting and dispositive power and no sole voting or dispositive authority.
The filing names Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang as reporting persons and certifies the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of enGene.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in enGene (ENGN) does Kynam Capital report?
Who are the reporting persons in this enGene (ENGN) Schedule 13G/A?
Is Kynam Capital’s enGene (ENGN) position intended to influence control of the company?
Why is this enGene (ENGN) ownership reported on Schedule 13G/A instead of 13D?
AI-generated analysis. How Rhea-AI works. Not financial advice.